Results 91 to 100 of about 12,173,986 (325)

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Barnes Hospital Bulletin [PDF]

, 1983
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1213/thumbnail ...

core   +4 more sources

Conferencias anatomoclínicas: caso no. veintitres

Revista de la Facultad de Medicina, 1955
Se hace una revisión de un caso clínico presentado en el Hospital San Juan de Dios, Bogotá.
Hospital San Juan de Dios
doaj  

Barnes Hospital Bulletin [PDF]

, 1967
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1018/thumbnail ...

core   +1 more source

Barnes Hospital Bulletin [PDF]

, 1985
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1234/thumbnail ...

core   +4 more sources

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Conferencias anatomoclínicas: caso no. diez y ocho

Revista de la Facultad de Medicina, 1955
L. M. B. 16 años. Ciudad de Origen y Procedencia: Susa. Servicio del Prof. Manuel José Luque. NOTA CLINICA: La enferma ingresa al Servicio de Clínica Quirúrgica el 18 de enero de 1952, por presentar un bocio.
San Juan de Dios Hospital
doaj  

ELECTROTHERAPY AT A BASE HOSPITAL. [PDF]

, 1915
W. J. Turrell
openalex   +1 more source

Barnes Hospital Bulletin [PDF]

, 1974
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1102/thumbnail ...

core   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source